SEC Filing Summary: Second Sight Medical Products, Inc.
Business Context and Reporting Period
This Form 8-K was filed by Second Sight Medical Products, Inc. on March 13, 2019. The report serves to disclose the company's financial and operating results for the three months and full year ended December 31, 2018. The registrant is an emerging growth company incorporated in California.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the press release furnished as Exhibit 99.1, which is referenced but not included in the body of this 8-K document.
Material Changes
No specific material changes or comparative data versus prior periods are detailed in the text of this filing. The document solely announces the issuance of the Q4 and full-year 2018 results.
Guidance, Outlook, and Risks
The filing does not contain management commentary, forward-looking guidance, risk factors, or details on contingencies. It explicitly states that the information in Items 2.02 and 7.01 is not deemed "filed" for purposes of Section 18 of the Exchange Act and is not incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for actual Q4 and full-year 2018 financial figures.
- Verify the company's status as an emerging growth company and its election regarding extended transition periods for accounting standards.
- Confirm that the financial data in the press release is not automatically incorporated by reference into other SEC filings.
- Note the discrepancy between the request metadata (Vivani Medical) and the filing registrant (Second Sight Medical Products, Inc.).